Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,227 | 15,045 | 28,918 | 17,116 | 19,055 |
| TOTAL | $7,934 | $16,426 | $29,511 | $17,943 | $21,570 |
| Non-Current Assets | |||||
| PPE Net | 174 | 367 | 607 | 872 | 905 |
| Other Non-Current Assets | 302 | 442 | 23 | 23 | 23 |
| TOTAL | $476 | $809 | $630 | $895 | $928 |
| Total Assets | $8,410 | $17,235 | $30,141 | $18,838 | $22,498 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 886 | 2,315 | 1,034 | 2,020 | 1,993 |
| Accrued Expenses | 1,793 | 2,711 | 2,251 | 3,600 | 2,940 |
| Other current liabilities | N/A | N/A | 99 | 4,173 | 14,824 |
| TOTAL | $2,966 | $5,275 | $3,384 | $9,793 | $19,757 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,057 | 13,094 | 12,652 | 12,773 | 1,040 |
| TOTAL | $12,984 | $13,017 | $12,598 | $12,455 | $492 |
| Total Liabilities | $15,950 | $18,292 | $15,982 | $22,248 | $20,249 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 519 | 68 | 62 | 15 | 13 |
| Common Shares | 29 | 17 | 15 | 4 | 117 |
| Retained earnings | -248,094 | -235,537 | -219,461 | -194,170 | -172,034 |
| Other shareholders' equity | -296 | 1,883 | 2,851 | -1,914 | -1,596 |
| TOTAL | $-7,540 | $-1,057 | $14,159 | $-3,410 | $2,249 |
| Total Liabilities And Equity | $8,410 | $17,235 | $30,141 | $18,838 | $22,498 |